Corrective Phases R...
Health Care: Drugs
BioDelivery Sciences International Inc. (BDSI: NASDAQ)
$3.17 -0.21 | -6.21%
06/04/12 - 04:00 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -23.33M | -13.03M | 33.05M | -17.23M |
| Operating Gains/Losses | -3.46M | -3.13M | 2.40K | -1.19M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 530.54K | 635.53K | -809.72K | -163.49K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 407.44K | 809.52K | 216.16K | -136.18K |
| (Decrease) Increase In Other Current Liabilities | 0.00 | -312.13K | -24.02M | 0.00 |
| (Increase) Decrease In Other Working Capital | 7.13K | 788.98K | 0.00 | 5.04M |
| Other Non-Cash Items | 1.23M | 1.24M | 8.85M | 2.93M |
| Net Cash From Continuing Operations | -23.27M | -11.68M | 18.19M | -9.82M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -23.27M | -11.68M | 18.19M | -9.82M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 375.04K |
| Purchases of Property, Plant & Equipment | -286.97K | -1.10M | -2.75M | -28.36K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | -375.04K |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 758.84K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -286.97K | -1.10M | -2.75M | 730.47K |
| Issuance of Debt | 7.80K | 0.00 | 1.83M | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 2.10M | 97.88K | 5.77M | 108.06K |
| Repayment of Long-Term Debt | 0.00 | -2.72M | -76.66K | -2.11M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 14.00M | 9.75M | 0.00 | -1.81M |
| Net Cash From Financing Activities | 16.10M | 7.12M | 7.53M | -3.81M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -7.46M | -5.66M | 22.97M | -12.89M |
Portfolios with BDSI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- UserWatchlist
- UserWhole Portfolio
- Userespwes06 Portfolio 1
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Stocks Under $5 Outperfo...
- Contributor10 Pharma Stocks With 100% ...
- UserSmall Cap Bargains to follo...
- UserPROS
- UserCloud66 - IRA
Latest BDSI Headlines from TheStreet
- 7 Stocks Under $10 Moving Higher 02.16.12 | 02:02 pm
- The Next Big Thing in Biotech: BIO CEO Conference
02.10.12 | 05:02 am - 10 Stocks Under $5 Outperforming in 2012 01.31.12 | 05:01 am
- Biotech Stock Mailbag: Adventrx Pharma 07.15.11 | 05:07 am
- BioDelivery Sciences International Inc. Stock Downgraded (BDSI) 04.01.11 | 06:04 pm
- IPO Watch: 2011 02.16.11 | 01:02 pm
- 10 Pharma Stocks With 100% Buy Ratings 02.03.11 | 11:02 am
- Rodman Rambles: Promising Biotechs 09.15.10 | 10:09 am
- Biotech Calendar: Key Dates for September 09.01.10 | 07:09 am
- Stock Offerings: MGIC Investment 04.20.10 | 11:04 am
Press Releases for BDSI
- BioDelivery Sciences To Present At The Jefferies 2012 Global Healthcare Conference - PR Newswire 05.31.12 | 07:05 am
- BioDelivery Sciences Receives $2.5 Million Milestone From Meda For BREAKYL In E.U. - PR Newswire 05.21.12 | 07:05 am
- BioDelivery Sciences Awarded Patent Resulting In $15 Million Milestone Payment - PR Newswire 04.17.12 | 07:04 am
- BioDelivery Sciences To Present At The Future Leaders In The Biotech Industry Conference - PR Newswire 04.16.12 | 08:04 am
- BioDelivery Sciences To Host Opioid Dependence Investor Event And Webcast On April 11, 2012 - PR Newswire 04.05.12 | 08:04 am
- BioDelivery Sciences Provides Business Review And Update In Conjunction With Filing Of Its Annual Report - PR Newswire 03.19.12 | 04:03 pm
- Federal Court Grants Request By BioDelivery Sciences For Stay Of MonoSol Litigation - PR Newswire 03.14.12 | 07:03 am
- ONSOLIS Relaunch Postponed Pending Product Modification - PR Newswire 03.12.12 | 07:03 am
- US Patent Office Rejection Of All Claims In Final Asserted MonoSol Patent Further Supports BioDelivery Sciences' Position - PR Newswire 03.06.12 | 09:03 am
- BioDelivery Sciences To Present At Cowen And ROTH Conferences - PR Newswire 03.05.12 | 07:03 am
Partner Headlines for BDSI
- BioDelivery's Spike May Be A Short-Lived Downer - Seeking Alpha 04.04.12 | 08:04 am
- Stocks To Watch: Week Of March 19-23 - Seeking Alpha 03.21.12 | 08:03 am
- BioDelivery Sciences Provides Business Review - Benzinga 03.19.12 | 04:03 pm
- Legal Developments Bode Well For BioDelivery Sciences - Seeking Alpha 03.15.12 | 08:03 am
- Biopharma Stocks To Watch This Week - Seeking Alpha 01.19.12 | 09:01 am
- Stocks To Watch This Week - Seeking Alpha 01.10.12 | 08:01 am
- This Week's Healthcare Stock Watch - Seeking Alpha 09.20.11 | 09:09 am
- Options Brief: BioDelivery Sciences International (BDSI) - Benzinga 12.28.10 | 09:12 am
- BioDelivery Sciences: Signs of Life - Seeking Alpha 09.10.10 | 03:09 pm
- BioDelivery Sciences Hopes to Increase Access to Cancer-Pain Drug - Fox Business 09.02.10 | 05:09 pm
